News

Innovate UK is to invest up to £8 million in collaborative R&D projects to stimulate the development of regenerative medicines and cell therapies in the UK.

The aim of this competition is to address the challenges of developing regenerative medicines and cell therapies as clinical treatments and commercial products. We are seeking proposals that advance the development and commercialisation of novel regenerative medicines and cell therapies. The focus is on the preclinical testing, clinical development and manufacture of regenerative medicines and cell therapies, and the development of underpinning tools and technologies.

Proposals must be collaborative and led by a business. We expect to fund mainly industrial research projects. Small businesses could receive up to 70% of their eligible project costs, medium-sized businesses 60% and large businesses 50%.

Innovate UK expect projects to range in size from total costs of £500,000 to £2.5 million, although we may consider projects outside this range.

For further information, key dates, briefing materials etc, visit the Innovate UK call webpage.